Risk of hemoptysis in patients with resected squamous cell and other high-risk lung cancers treated with adjuvant bevacizumab
Titel:
Risk of hemoptysis in patients with resected squamous cell and other high-risk lung cancers treated with adjuvant bevacizumab
Auteur:
Hellmann, Matthew D. Chaft, Jamie E. Rusch, Valerie Ginsberg, Michelle S. Finley, David J. Kris, Mark G. Price, Katharine A. R. Azzoli, Christopher. G. Fury, Matthew G. Riely, Gregory J. Krug, Lee M. Downey, Robert J. Bains, Manjit S. Sima, Camelia S. Rizk, Nabil Travis, William D. Rizvi, Naiyer A. Paik, Paul K.